Insmed reports Phase 2b study of brensocatib did not meet efficacy endpoints

Gilead to acquire Tubulis to expand ADC oncology capabilities

FDA grants Fast Track status to SIM0505 for platinum‑resistant ovarian cancer

Sanofi reports positive phase 2 results for lunsekimig in asthma and CRSwNP

Aelis Farma secures EUR458k France 2030 grant to advance metabolic disease programme

Immedica Pharma gains European approval to extend Efmody use in adrenal insufficiency

NeuroSense's PrimeC composition receives Brazilian patent

Akeso reports updated data on cadonilimab combination therapy in PD-(L)1 inhibitor-resistant advanced NSCLC data

AstraZeneca reports positive Phase III data for Imfinzi and Imjudo in liver cancer

Caliway to present preclinical data on CBL-514 in combination with GLP-1R therapy at ADA 2026 Scientific Sessions

Thermo Fisher Scientific unveils CHOvantage GS Kit to speed biologics development

Frontier Medicines licenses FMC-220 oncology programme to LG Chem in global deal

NJ Bio and Aji Bio-Pharma partner to strengthen support for ADC development

Alltrna granted approval for first-in-human clinical trial of AP003

Lilly to acquire Centessa Pharmaceuticals for up to USD47 per share